94 Results for "

glycogen synthase

" in MedChemExpress (MCE) Product Catalog:
Products (94)

94 Results for "glycogen synthase" in MCE Product Catalog:

22
22 Cited Publications
Cat. No.: HY-16294
CAS No.: 603288-22-8
Target:  

GSK-3

Research Areas:  

Cancer

LY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β, respectively.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-15424
CAS No.: 24386-93-4
Purity:  99.64%
Synonyms: NSC 113939; 5-ITu
Target:  

Adenosine Kinase

Research Areas:  

Cancer

5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-113914
CAS No.: 1034895-42-5
Purity:  99.13%
Synonyms: Elraglusib
Target:  

GSK-3 Apoptosis Autophagy

Research Areas:  

Cancer

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-157646
CAS No.: 2839908-40-4
Purity:  98.98%
Synonyms: GYS1-IN-2
Target:  

Glycosyltransferase

Research Areas:  

Metabolic Disease

MZ-101 (GYS1-IN-2) is an orally active, potent and selective small-molecule glycogen synthase 1 (GYS1) inhibitor with with an IC50 value of 0.041 µM. MZ-101 reduces glycogen concentrations in cells and in mice. MZ-101 can used to study GYS1 -mediated Pompe disease and other glycogen storage diseases .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-59090
CAS No.: 676596-65-9
Synonyms: 1-Akp
Target:  

GSK-3

1-Azakenpaullone (1-Akp) is a highly selective and ATP-competitive inhibitor of glycogen synthase kinase-3 β (GSK-3β), with an IC50 value of 18 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124607B
CAS No.: 2056262-07-6
Purity:  98.21%
Target:  

GSK-3

BRD3731 is a selective GSK3β inhibitor, with IC50s of 15 nM and 215 nM for GSK3β and GSK3α, respectively. BRD3731 is potentail for the research of post-traumatic stress disorder (PTSD), psychiatric disorder, diabetes, and neurodegenerative disorders .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0315
CAS No.: 171783-05-4
Target:  

Akt

Research Areas:  

Others

Crosstide is a peptide analog of glycogen synthase kinase α/β fusion protein sequence which is a substrate for Akt.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-131062
CAS No.: 2415003-97-1
Purity:  98.69%
Target:  

Glycosyltransferase

Research Areas:  

Metabolic Disease

yGsy2p-IN-1 is a potent inhibitor for yeast glycogen synthase 2 (yGsy2p). yGsy2p-IN-1 is a competitive human glycogen synthase 1 (hGYS1) inhibitor with an IC50 of 2.75 μM and a Ki of 1.31 μM for wild-type hGYS1. yGsy2p-IN-H23 a pyrazole inhibitor, is used for glycogen storage diseases (GSDs) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P80820
Synonyms: GSK3B; glycogen synthase kinase-3 beta; GSK-3 beta; Serine/threonine-protein kinase GSK3B

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121035
CAS No.: 916440-85-2
Purity:  99.20%
Synonyms: 7-Bromoindirubin-3-Oxime
Target:  

CDK GSK-3

Research Areas:  

Neurological Disease

7BIO (7-Bromoindirubin-3-Oxime) is the derivate of indirubin. 7BIO (7-Bromoindirubin-3-Oxime) has inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β). 7BIO (7-Bromoindirubin-3-Oxime) inhibits Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, activation of astrocytes and microglia, and attenuates Aβ oligomer-induced cognitive impairments in mice [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141480
CAS No.: 1448990-73-5
Purity:  99.22%
Target:  

GSK-3 Apoptosis

Research Areas:  

Cancer

GSK-3β inhibitor 3 is a potent, selective, irreversible and covalent inhibitor of Glycogen Synthase Kinase 3β (GSK-3β), with an IC50 of 6.6 μM. GSK-3β inhibitor 3 can be used for the research of acute promyelocytic leukemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112388
CAS No.: 626604-39-5
Purity:  99.10%
Target:  

GSK-3

GSK-3b Inhibitor XI (Compound 33) is a potent and selective GSK3β inhibitor, with a Ki value of 25 nM. GSK-3b Inhibitor XI increases glycogen synthase (GS) activity. GSK-3b Inhibitor XI can be used for research on type 2 diabetes and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-107531
CAS No.: 1384424-80-9
Purity:  99.87%
Target:  

GSK-3

Research Areas:  

Neurological Disease Cancer

A 1070722 is a potent and selective glycogen synthase kinase 3 (GSK-3) inhibitor, with a Ki of 0.6 nM for both GSK-3α and GSK-3β. A 1070722 can penetrate the blood-brain barrier (BBB) and accumulates in brain regions, thus potential for PET radiotracer for the quantification of GSK-3 in brain. A 1070722 decreases spontaneous locomotion .
loading...
    loading...
Cat. No.: HY-139254
CAS No.: 667463-82-3
Purity:  99.10%
Synonyms: IDR3O; I3O
Target:  

CDK GSK-3 JNK Wnt

Research Areas:  

Neurological Disease

Indirubin-3′-oxime (IDR3O), a synthetic derivative of indirubin, is a potent inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3β (GSK3β). Indirubin-3′-oxime directly inhibits the activity of all three isoforms of JNK (JNK1, JNK2, and JNK3), with IC50s of 0.8 μM, 1.4 μM, and 1.0 μM, respectively. Indirubin-3′-oxime can enhance height growth via activation of Wnt/β-catenin signaling in chondrocytes .
loading...
    loading...
Cat. No.: HY-122026
CAS No.: 1962178-27-3
Purity:  98.43%
Synonyms: PF-367
Target:  

GSK-3

Research Areas:  

Neurological Disease

PF-04802367 (PF-367) is a highly selective GSK-3 inhibitor with an IC50 of 2.1 nM based on a recombinant human GSK-3β enzyme assay and 1.1 nM based on ADP-Glo assay. PF-04802367 shows desirable central nervous system (CNS) properties and potency. PF-04802367 is equally effective at inhibition of the two known GSK-3 isoforms (GSK-3α and GSK-3β) with IC50 values of 10.0 and 9.0 nM in mobility shift assays, respectively .
loading...
    loading...
Cat. No.: HY-P10605
CAS No.: 496856-73-6
Target:  

Akt GSK-3

Research Areas:  

Cancer

GSK3β-peptide is a substrate mimetic peptide of glycogen synthase kinase 3-β (GSK3-β) that can bind to the active site of GSK3-β and mimic the behavior of a real substrate. GSK3β-peptide can be used to develop substrate mimetic inhibitors of Akt as potential anticancer drugs .
loading...
    loading...
Cat. No.: HY-Q48328
CAS No.: 478482-74-5
Target:  

GSK-3

Research Areas:  

Metabolic Disease

GSK3-IN-1 (compound 11) is a GSK-3 inhibitor with an IC50 value of 12 μM. GSK3-IN-1 can be used in the research of diabetes .
loading...
    loading...
Cat. No.: HY-107815
CAS No.: 556813-39-9
Purity:  98.08%
Target:  

GSK-3

Research Areas:  

Neurological Disease

CHIR 98024 (Compound L) is a glycogen synthase kinase 3 (GSK3) inhibitor with an EC50 of 0.2566 μM .
loading...
    loading...
Cat. No.: HY-P2558
Target:  

GSK-3

Research Areas:  

Others

GSK3 Substrate, α, β subunit is peptide substrate for glycogen synthase kinase-3 (GSK-3) and can be used to measure GSK-3 activity .
loading...
    loading...
Cat. No.: HY-15424R
CAS No.: 24386-93-4
Synonyms: NSC 113939 (Standard); 5-ITu (Standard)
Research Areas:  

Cancer

5-Iodotubercidin (Standard) is the analytical standard of 5-Iodotubercidin. This product is intended for research and analytical applications. 5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin (NSC 113939) initiates glycogen synthesis in isolated hepatocytes by causing inactivation of phosphorylase and activation of glycogen synthase. 5-Iodotubercidin (NSC 113939) also inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC and Haspin .
loading...
    loading...